Skip to main content
Log in

Die Rolle von Erythropoietin bei der Verbesserung der Wundheilung

The role of erythropoietin in improvement of wound healing

  • Übersichten
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Pleiotrope Substanzen sind durch ihr ausgesprochen vielfältiges und komplexes Wirkspektrum charakterisiert und dies macht sie für die Therapie von Wunden attraktiv. Neben seinem bekannten Effekt der Steigerung der Hämatopoese konnte das Glykoproteinhormon Erythropoietin (EPO) in diversen anderen Organen eine deutliche Gewebeprotektion aufzeigen. Der Einsatz von EPO im Rahmen von Regenerationsprozessen der Haut basiert hier wahrscheinlich im Wesentlichen auf seiner zytoprotektiven, proangiogenen, antiapoptotischen sowie antiinflammatorischen Wirksamkeit. Hier kann EPO durch eine niedrigdosierte bzw. einmalige Applikation die strukturelle und koordinierte Interaktion verschiendener Zelltypen untereinander stimulieren. Diese Übersichtsarbeit soll die Vor- und Nachteile einer EPO-Gabe im Rahmen verschiedener Heilungs- und Regenerationsvorgänge der Haut aus der experimentellen Forschung beleuchten und mögliche klinische Anwendungen diskutieren.

Abstract

Pleiotropic substances are characterized by their versatile and complex range of actions which makes them potential new active agents for the therapy of wounds. Besides its known effect to increase red blood cell production, the glycoprotein hormone erythropoietin (EPO) has been found to demonstrate a tissue protective effect in several other organs. The administration of EPO during skin wound healing is most likely essentially based on its cytopotective, proangiogenic, antiapoptotic and antiinflammatory effects. Herein EPO stimulates a coordinated interaction of different types of cells at a low or only a single dose. This review article aims to present the advantages and disadvantages of EPO administration in different experimental models to study the healing and regeneration processes of the skin and discusses possible clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Bodó E, Kromminga A, Funk W et al (2007) Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J 21:3346–3354

    Article  PubMed  Google Scholar 

  2. Bonsdorff E, Jalavisto E (1948) A humoral mechanism in anoxic erythrocytosis. Acta Physiol Scand 16:150–170

    Article  CAS  Google Scholar 

  3. Buemi M, Galeano M, Sturiale A et al (2004) Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22:169–173

    Article  CAS  PubMed  Google Scholar 

  4. Buemi M, Lacquaniti A, Bolignano D et al (2009) Down with the erythropoietin. Long live the erythropoietin! Curr Drug Targets 10:1028–1032

    Article  CAS  PubMed  Google Scholar 

  5. Carnot P, Deflandre C (1906) Sur l‘activité hémopoiétique du sérum au cours de la régénération du sang. C R Acad Sci 143:384–386

    CAS  Google Scholar 

  6. Desmouliere A, Badid C, Lochaton-Piallat BM, Gabbiani G (1997) Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol 29:19–30

    Article  CAS  PubMed  Google Scholar 

  7. Drüeke TB, Locatelli F, Clyne N et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071–2084

    Article  PubMed  Google Scholar 

  8. Erbayraktar Z, Erbayraktar S, Yilmaz O et al (2009) Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol Med 15:235–241

    Article  CAS  PubMed  Google Scholar 

  9. Fatouros MS, Vekinis G, Bourantas KL et al (1999) Influence of growth factors erythropoietin and granulocyte macrophage colony stimulating factor on mechanical strength and healing of colonic anastomoses in rats. Eur J Surg 165:986–992

    Article  CAS  PubMed  Google Scholar 

  10. Ferri C, Giuggioli D, Sebastiani M, Colaci M (2007) Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol 32:287–290

    Article  CAS  PubMed  Google Scholar 

  11. Fishbane S, Ragolia L, Palaia T et al (2004) Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int 65:452–458

    Article  CAS  PubMed  Google Scholar 

  12. Gaillard N, Mania A, Brunel H et al (2009) Interferon-alfa- and erythropoetin-associated cerebral vasoconstriction. Cephalalgia 29:1340–1343

    Article  CAS  PubMed  Google Scholar 

  13. Galeano M, Altavilla D, Bitto A et al (2006) Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med 34:1139–1146

    Article  CAS  PubMed  Google Scholar 

  14. Galeano M, Altavilla D, Cucinotta D et al (2004) Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53:2509–2517

    Article  CAS  PubMed  Google Scholar 

  15. Ghezzi P, Brines M (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11(Suppl 1):37–44

    Article  Google Scholar 

  16. Greenhalgh DG (1998) The role of apoptosis in wound healing. Int J Biochem Cell Biol 30:1019–1030

    Article  CAS  PubMed  Google Scholar 

  17. Haroon ZA, Amin K, Jiang X, Arcasoy MO (2003) A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163:993–1000

    CAS  PubMed  Google Scholar 

  18. Huang J, Li CY, Mesa RA et al (2008) Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer 112:2726–2732

    Article  PubMed  Google Scholar 

  19. Jelkmann W (2000) Use of recombinant human erythropoietin as an antianemic and performance enhancing drug. Curr Pharm Biotechnol 1:11–31

    Article  CAS  PubMed  Google Scholar 

  20. Keast DH, Fraser C (2004) Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases. Ostomy Wound Manage 50:64–70

    PubMed  Google Scholar 

  21. Le Minh K, Klemm K, Abshagen K et al (2007) Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol 170:1954–1963

    Article  Google Scholar 

  22. Löser M (2008) Synthese und Sekretion von Erythropoetin durch genetisch modifizierte Zellen der Haut. Dissertation Ludwig-Maximilians-Universität München

  23. Quaschning T, Ruschitzka F, Stallmach T et al (2003) Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB J 17:259–261

    CAS  PubMed  Google Scholar 

  24. Ribatti D, Presta M, Vacca A et al (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627–2636

    CAS  PubMed  Google Scholar 

  25. Sakanaka M, Wen TC, Matsuda S et al (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95:4635–4640

    Article  CAS  PubMed  Google Scholar 

  26. Saray A, Ozakpinar R, Koc C et al (2003) Effect of chronic and short-term erythropoietin treatment on random flap survival in rats: an experimental study. Laryngoscope 113:85–89

    Article  CAS  PubMed  Google Scholar 

  27. Savino R, Ciliberto G (2004) A paradigm shift for erythropoietin: no longer a special ized growth factor, but rather an all-purpose tissue-protective agent. Cell Death Differ 11(Suppl 1):2–4

    Article  Google Scholar 

  28. Sorg H, Krueger C, Schulz T et al (2009) Effects of erythropoietin in skin wound healing are dose related. FASEB J 23:3049–3058

    Article  CAS  PubMed  Google Scholar 

  29. Vachharajani V, Vital S, Russell J (2010) Modulation of circulating cell-endothelial cell interaction by erythropoietin in lean and obese mice with cecal ligation and puncture. Pathophysiology 17:9–18

    Article  CAS  PubMed  Google Scholar 

  30. Vaziri ND (2001) Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens 10:633–637

    Article  CAS  PubMed  Google Scholar 

  31. Wish JB, Coyne DW (2007) Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies. Mayo Clin Proc 82:1371–1380

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Sorg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sorg, H., Kuhbier, J., Menger, B. et al. Die Rolle von Erythropoietin bei der Verbesserung der Wundheilung. Chirurg 81, 993–998 (2010). https://doi.org/10.1007/s00104-010-1978-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-010-1978-3

Schlüsselwörter

Keywords

Navigation